All authors

Dave Holmes-Kinsella

Data Team

headshot_bw_circle_white_bg

An illustration of two pill bottles, with shadows cast in the shape of dollar signs on a light blue background.
When people talk about the cost of GLP-1 medications, the conversation usually centers on the drugs themselves. Our latest analysis suggests something different: what patients pay often depends less on the medication than on the label attached to it. By analyzing more than 165,000 insurance verification transactions processed on the Infinitus platform in 2026, we...